+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Brain Imaging Modalities Market by Type, Patient Type, End-Users - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 181 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5925067
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Brain Imaging Modalities Market grew from USD 10.37 billion in 2023 to USD 10.99 billion in 2024. It is expected to continue growing at a CAGR of 6.35%, reaching USD 15.96 billion by 2030.

Brain imaging modalities encompass various technologies used to visualize the structure and function of the brain. This sector includes magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), electroencephalography (EEG), and functional MRI (fMRI), among others. The necessity of these modalities is underscored by their vital role in diagnosing neurological conditions, assessing treatment efficacy, and advancing neuroscience research. They are applied in hospitals, research institutes, and diagnostic clinics, serving end-users such as neurologists, psychiatrists, and researchers. The market is primarily driven by advances in imaging technology, increasing prevalence of neurological disorders, and heightened demand for non-invasive diagnostic options. Additionally, rising investment in healthcare infrastructure and research in developing countries presents significant growth opportunities. However, market expansion is impeded by high costs of installation and maintenance, potential safety issues, and technical expertise requirements. Furthermore, regulatory hurdles in the approval processes pose a challenge. Growth can be fostered by focusing on cost-effective innovations, enhancing image resolution, and integrating AI to improve diagnostic precision and efficiency. Developing portable and wearable imaging devices is also promising, particularly for remote and underserved regions. The brain imaging market continues to evolve with technological advancements in machine learning and big data analytics, offering potential to streamline operations and personalize treatment plans. A key recommendation for companies is to invest in collaborative R&D with academic institutions to pioneer breakthroughs in both hardware and imaging algorithms. Keeping abreast of regulatory changes and fostering partnerships with healthcare providers can also drive market penetration. As the demand for precision medicine increases, brain imaging modalities are likely to become more ingrained in routine healthcare, making this a dynamic and rapidly growing market with substantial opportunities for innovation and expansion.

Understanding Market Dynamics in the Brain Imaging Modalities Market

The Brain Imaging Modalities Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing incidence of dementia, Alzhiemer’s, and brain cancer worldwide
    • Government initiatives promoting brain disease awareness and screening
    • Rising popularity of neuroimaging for brain disease diagnosis
  • Market Restraints
    • Technical limitations related to radiation exposure of brain imaging modality software
  • Market Opportunities
    • Integration of AI & ML in the brain imaging modality software
    • Establishment of new brain disease diagnosis centers adopting digital solutions
  • Market Challenges
    • Concerns associated with data privacy and security breaches

Exploring Porter’s Five Forces for the Brain Imaging Modalities Market

Porter’s Five Forces framework further strengthens the insights of the Brain Imaging Modalities Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Brain Imaging Modalities Market

External macro-environmental factors deeply influence the performance of the Brain Imaging Modalities Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Brain Imaging Modalities Market

The Brain Imaging Modalities Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Brain Imaging Modalities Market

The Brain Imaging Modalities Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Brain Imaging Modalities Market

The Brain Imaging Modalities Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Brain Imaging Modalities Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Advantis Medical Imaging, AiM Medical Robotics, Boston Scientific Corporation, Bruker Corporation, Canon Medical Systems Corporation, Elekta AB, EMVision Medical Devices Ltd., Esaote SpA, Fujifilm Holdings Corporation, GE HealthCare Technologies, Inc., Hitachi, Ltd., Hologic, Inc., Hyperfine Research, Inc., Magnetic Insight, Inc., Medtronic PLC, Octave Biosciences, Promaxo, Inc., Royal Philips, Shimadzu Corporation, Siemens AG, Thermo Fisher Scientific Inc., and Toshiba Corporation.

Market Segmentation & Coverage

This research report categorizes the Brain Imaging Modalities Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Type
    • Computed Tomography
    • Electroencephalography
    • Functional Magnetic Resonance Imaging
    • Magnetoencephalography
    • Near Infrared Spectroscopy
    • Positron Emission Tomography
  • Patient Type
    • Adults & Paediatrics
    • Infants
  • End-Users
    • Diagnostic Imaging Centers
    • Hospitals & Clinics
    • Pharmaceutical and Biotechnology Companies
    • Research Institutions
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidence of dementia, Alzhiemer’s, and brain cancer worldwide
5.1.1.2. Government initiatives promoting brain disease awareness and screening
5.1.1.3. Rising popularity of neuroimaging for brain disease diagnosis
5.1.2. Restraints
5.1.2.1. Technical limitations related to radiation exposure of brain imaging modality software
5.1.3. Opportunities
5.1.3.1. Integration of AI & ML in the brain imaging modality software
5.1.3.2. Establishment of new brain disease diagnosis centers adopting digital solutions
5.1.4. Challenges
5.1.4.1. Concerns associated with data privacy and security breaches
5.2. Market Segmentation Analysis
5.2.1. Type: Higher deployment of computed tomography owing to detailed anatomical images
5.2.2. End-Users: Extending applications of brain imaging modalities in diagnostic imaging centers due to high-resolution imaging capabilities
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Brain Imaging Modalities Market, by Type
6.1. Introduction
6.2. Computed Tomography
6.3. Electroencephalography
6.4. Functional Magnetic Resonance Imaging
6.5. Magnetoencephalography
6.6. Near Infrared Spectroscopy
6.7. Positron Emission Tomography
7. Brain Imaging Modalities Market, by Patient Type
7.1. Introduction
7.2. Adults & Paediatrics
7.3. Infants
8. Brain Imaging Modalities Market, by End-Users
8.1. Introduction
8.2. Diagnostic Imaging Centers
8.3. Hospitals & Clinics
8.4. Pharmaceutical and Biotechnology Companies
8.5. Research Institutions
9. Americas Brain Imaging Modalities Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Brain Imaging Modalities Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Brain Imaging Modalities Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Brainet and SimonMed imaging forge partnership to revolutionize neurodegenerative disease diagnosis with AI and advanced fMRI techniques
12.3.2. EMVision Secures USD 10 million from Keysight Technologies to propel Portable Brain Imaging
12.3.3. Philips and Synthetic MR unveil Smart Quant Neuro 3D, AI-driven breakthrough in quantitative brain imaging to transform neurology care
12.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. BRAIN IMAGING MODALITIES MARKET RESEARCH PROCESS
FIGURE 2. BRAIN IMAGING MODALITIES MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
FIGURE 11. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS BRAIN IMAGING MODALITIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS BRAIN IMAGING MODALITIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES BRAIN IMAGING MODALITIES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES BRAIN IMAGING MODALITIES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC BRAIN IMAGING MODALITIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC BRAIN IMAGING MODALITIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. BRAIN IMAGING MODALITIES MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. BRAIN IMAGING MODALITIES MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. BRAIN IMAGING MODALITIES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. BRAIN IMAGING MODALITIES MARKET DYNAMICS
TABLE 7. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY FUNCTIONAL MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY NEAR INFRARED SPECTROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY POSITRON EMISSION TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY ADULTS & PAEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY INFANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL BRAIN IMAGING MODALITIES MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS BRAIN IMAGING MODALITIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 31. BRAZIL BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 32. CANADA BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 33. CANADA BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 34. CANADA BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 35. MEXICO BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 36. MEXICO BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 37. MEXICO BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES BRAIN IMAGING MODALITIES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 44. ASIA-PACIFIC BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 45. ASIA-PACIFIC BRAIN IMAGING MODALITIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 46. AUSTRALIA BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 47. AUSTRALIA BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 48. AUSTRALIA BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 49. CHINA BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. CHINA BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 51. CHINA BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 52. INDIA BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53. INDIA BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 54. INDIA BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 55. INDONESIA BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 56. INDONESIA BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 57. INDONESIA BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 58. JAPAN BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 59. JAPAN BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 60. JAPAN BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 61. MALAYSIA BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 62. MALAYSIA BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 63. MALAYSIA BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 64. PHILIPPINES BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 65. PHILIPPINES BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 66. PHILIPPINES BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 67. SINGAPORE BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 68. SINGAPORE BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 69. SINGAPORE BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 70. SOUTH KOREA BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 71. SOUTH KOREA BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 72. SOUTH KOREA BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 73. TAIWAN BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 74. TAIWAN BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 75. TAIWAN BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 76. THAILAND BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. THAILAND BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 78. THAILAND BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 79. VIETNAM BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 80. VIETNAM BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 81. VIETNAM BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 86. DENMARK BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. DENMARK BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 88. DENMARK BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 89. EGYPT BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 90. EGYPT BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 91. EGYPT BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 92. FINLAND BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 93. FINLAND BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 94. FINLAND BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 95. FRANCE BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 96. FRANCE BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 97. FRANCE BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 98. GERMANY BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 99. GERMANY BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 100. GERMANY BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 101. ISRAEL BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 102. ISRAEL BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 103. ISRAEL BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 104. ITALY BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 105. ITALY BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 106. ITALY BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 107. NETHERLANDS BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 108. NETHERLANDS BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 109. NETHERLANDS BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 110. NIGERIA BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 111. NIGERIA BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 112. NIGERIA BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 113. NORWAY BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 114. NORWAY BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 115. NORWAY BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 116. POLAND BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 117. POLAND BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 118. POLAND BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 119. QATAR BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 120. QATAR BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 121. QATAR BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 126. SAUDI ARABIA BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 127. SAUDI ARABIA BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 129. SOUTH AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 130. SOUTH AFRICA BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 131. SPAIN BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 132. SPAIN BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 133. SPAIN BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 135. SWEDEN BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 136. SWEDEN BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 137. SWITZERLAND BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 138. SWITZERLAND BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 139. SWITZERLAND BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 140. TURKEY BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 141. TURKEY BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 142. TURKEY BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 145. UNITED ARAB EMIRATES BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM BRAIN IMAGING MODALITIES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM BRAIN IMAGING MODALITIES MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
TABLE 148. UNITED KINGDOM BRAIN IMAGING MODALITIES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 149. BRAIN IMAGING MODALITIES MARKET SHARE, BY KEY PLAYER, 2023
TABLE 150. BRAIN IMAGING MODALITIES MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Brain Imaging Modalities Market, which are profiled in this report, include:
  • Abbott Laboratories
  • Advantis Medical Imaging
  • AiM Medical Robotics
  • Boston Scientific Corporation
  • Bruker Corporation
  • Canon Medical Systems Corporation
  • Elekta AB
  • EMVision Medical Devices Ltd.
  • Esaote SpA
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies, Inc.
  • Hitachi, Ltd.
  • Hologic, Inc.
  • Hyperfine Research, Inc.
  • Magnetic Insight, Inc.
  • Medtronic PLC
  • Octave Biosciences
  • Promaxo, Inc.
  • Royal Philips
  • Shimadzu Corporation
  • Siemens AG
  • Thermo Fisher Scientific Inc.
  • Toshiba Corporation

Methodology

Loading
LOADING...

Table Information